Abstract:The significance of NSUN2 in carcinogenesis is gradually being recognized, yet a comprehensive analysis across pan-cancer remains a pivotal void in existing research. In our investigation, we capitalized on the UCSC Xena platform to evaluate NSUN2 expression levels and their prognostic implications across a range of cancer types. Furthermore, we employed the cBioPortal database to delve into the genomic variations of NSUN2 within human cancers. Our study encompassed the use of molecular docking, genomic tumor profiling, and an assessment of the gene's responsiveness to pharmacological treatments. Additionally, we utilized algorithmic techniques to measure the relationship between NSUN2 expression and key clinical biomarkers, such as microsatellite instability (MSI), tumor mutational burden (TMB), and immune cell infiltration. Our results have established a notable association between NSUN2 and endometrial cancer (UCEC), thereby confirming its clinical significance through an analysis of tumoral expression patterns, mutational spectra, methylation profiles, and drug sensitivity. Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) were crucial tools in elucidating the biological roles of NSUN2 in endometrial cancer. Consistently, elevated NSUN2 expression was associated with unfavorable clinical outcomes and was primarily observed in the context of genetic amplifications. Across 22 distinct tumor types, our analysis revealed a notable correlation between NSUN2 expression and various metrics related to immune cell infiltration, tumor stroma, and immune scores. Notably, higher levels of NSUN2 expression have been linked to a reduced response to certain chemotherapeutic agents, including PHA-793887. In UCEC, a positive correlation between NSUN2 methylation and gene expression hints at a potential epigenetic regulatory mechanism underlying cancer progression. Our study highlights the potential of NSUN2 as a key oncogene and its promising role as a therapeutic target as well as a prognostic biomarker for endometrial cancer. This underscores its potential importance in predicting responses to immunotherapy.

SUN2: A potential therapeutic target in cancer (Review)

Overexpression of Nsun2 by Dna Hypomethylation is Associated with Metastatic Progression in Human Breast Cancer

SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer

Downregulation Of Sun2 Promotes Metastasis Of Colon Cancer By Activating Bdnf/Trkb Signalling By Interacting With Sirt1

Downregulation of <scp>SUN2</scp> promotes metastasis of colon cancer by activating <scp>BDNF</scp>/<scp>TrkB</scp> signalling by interacting with <scp>SIRT1</scp>

Elevated Sad1 and UNC84 Domain Containing 2 (SUN2) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA)

NSUN2-mediated RNA methylation: Molecular mechanisms and clinical relevance in cancer

The role of SIRT2 in cancer: A novel therapeutic target

Loss of Sun2 Promotes the Progression of Prostate Cancer by Regulating Fatty Acid Oxidation.

Pancancer Analysis of NSUN2 with a Focus on Prognostic and Immunological Roles in Endometrial Cancer

Bipyridine Derivatives As NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer.

NOP2/Sun RNA Methyltransferase 2 is a Potential Pan-Cancer Prognostic Biomarker and is Related to Immunity

Functional characterization of SOX2 as an anticancer target

N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma

Suppression of NSUN2 Enhances the Sensitivity to Chemosensitivity and Inhibits Proliferation by Mediating Cell Apoptosis in Gastric Cancer.

FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development

Targeting SHP2 As a Promising Strategy for Cancer Immunotherapy

Targeting Sirtuins for Cancer Therapy: Epigenetics Modifications and Beyond

The dual role of sirtuins in cancer: biological functions and implications

NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner